Leonard Frank X's Form 4 filing
NovoCure Ltd (NVCR) · filed Jun 4, 2025
- Accession no.
- 0001562180-25-004426
- Filed
- Jun 4, 2025
- Trade date
- Jun 2, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $528.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Leonard Frank XCIK 0001822879 | Officer (EVP, Pres., Novocure Oncology) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 2, 2025 | Ordinary Shares | SSaleDisposed | −21,717 | $17.22 | −$373,966.74 | 176,931 | Direct | |
| Jun 2, 2025 | Ordinary Shares | SSaleDisposed | −6,600 | $17.99 | −$118,734 | 170,331 | Direct | |
| Jun 2, 2025 | Ordinary Shares | SSaleDisposed | −1,879 | $19.01 | −$35,719.79 | 168,452 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.